Birdwatch Archive

Birdwatch Note

2024-03-08 11:57:06 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

mRNA technology has garnered significant attention in cancer research. mRNA technology holds promise for both infectious diseases & cancer treatment. As research progresses, we may witness breakthroughs that revolutionize how we beat cancer & other illnesses. https://www.scientificamerican.com/article/new-cancer-vaccines-could-treat-some-types-of-pancreatic-colorectal-and-other-deadly-forms-of-the-disease/ https://www.cancer.gov/news-events/cancer-currents-blog/2022/mrna-vaccines-to-treat-cancer https://www.alcimed.com/en/insights/mrna-cancer-therapy/ https://www.aamc.org/news/mrna-technology-promises-revolutionize-future-vaccines-and-treatments-cancer-infectious-diseases https://cancerblog.mayoclinic.org/2022/01/11/mayo-clinic-research-finds-immune-system-responds-to-mrna-treatment-for-cancer/

Written by 5CB448A5B8D03939ABCA5A0BB4667E78774F5C2DC839ACED0E98DA7D7131EDBA
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1765967320050983302

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1766070636202406023
  • noteId - 1766070636202406023
  • participantId -
  • noteAuthorParticipantId - 5CB448A5B8D03939ABCA5A0BB4667E78774F5C2DC839ACED0E98DA7D7131EDBA
  • createdAtMillis - 1709899026334
  • tweetId - 1765967320050983302
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 0
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • mRNA technology has garnered significant attention in cancer research. mRNA technology holds promise for both infectious diseases & cancer treatment. As research progresses, we may witness breakthroughs that revolutionize how we beat cancer & other illnesses. https://www.scientificamerican.com/article/new-cancer-vaccines-could-treat-some-types-of-pancreatic-colorectal-and-other-deadly-forms-of-the-disease/ https://www.cancer.gov/news-events/cancer-currents-blog/2022/mrna-vaccines-to-treat-cancer https://www.alcimed.com/en/insights/mrna-cancer-therapy/ https://www.aamc.org/news/mrna-technology-promises-revolutionize-future-vaccines-and-treatments-cancer-infectious-diseases https://cancerblog.mayoclinic.org/2022/01/11/mayo-clinic-research-finds-immune-system-responds-to-mrna-treatment-for-cancer/

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2024-03-08 11:57:06 UTC
(1709899026334)
2024-03-08 18:14:15 UTC
(1709921655502)
CURRENTLY_RATED_HELPFUL 2024-03-10 02:46:15 UTC
(1710038775311)
CURRENTLY_RATED_HELPFUL 2024-03-08 18:14:15 UTC
(1709921655502)
CURRENTLY_RATED_HELPFUL

Note Ratings

rated at rated by
2024-03-08 14:55:51 -0600 Rating Details
2024-03-08 11:13:17 -0600 Rating Details
2024-03-08 10:05:59 -0600 Rating Details
2024-03-08 09:53:16 -0600 Rating Details
2024-03-08 08:12:23 -0600 Rating Details
2024-03-08 07:34:25 -0600 Rating Details
2024-03-08 07:30:45 -0600 Rating Details
2024-03-08 07:26:18 -0600 Rating Details
2024-03-08 07:11:21 -0600 Rating Details
2024-03-08 06:37:16 -0600 Rating Details
2024-03-08 06:25:21 -0600 Rating Details
2024-03-08 06:21:00 -0600 Rating Details
2024-03-08 06:20:05 -0600 Rating Details
2024-03-08 06:19:39 -0600 Rating Details
2024-03-08 06:15:35 -0600 Rating Details
2024-03-08 06:02:35 -0600 Rating Details
2024-03-08 11:47:01 -0600 Rating Details
2024-03-08 10:47:43 -0600 Rating Details
2024-03-08 10:22:38 -0600 Rating Details
2024-03-08 08:31:39 -0600 Rating Details
2024-03-08 08:16:10 -0600 Rating Details
2024-03-08 08:00:05 -0600 Rating Details
2024-03-08 07:24:31 -0600 Rating Details
2024-03-08 06:44:45 -0600 Rating Details
2024-03-08 06:33:55 -0600 Rating Details
2024-03-08 06:29:44 -0600 Rating Details
2024-03-08 06:21:33 -0600 Rating Details
2024-03-08 06:15:09 -0600 Rating Details
2024-03-08 06:08:13 -0600 Rating Details
2024-03-08 05:59:45 -0600 Rating Details
2024-03-08 05:58:36 -0600 Rating Details
2024-03-09 08:26:27 -0600 Rating Details
2024-03-08 08:06:57 -0600 Rating Details
2024-03-08 07:46:46 -0600 Rating Details
2024-03-08 07:44:20 -0600 Rating Details
2024-03-08 07:25:50 -0600 Rating Details
2024-03-08 07:04:38 -0600 Rating Details
2024-03-08 06:44:40 -0600 Rating Details
2024-03-08 06:34:44 -0600 Rating Details
2024-03-08 06:33:02 -0600 Rating Details
2024-03-08 06:23:34 -0600 Rating Details
2024-03-08 06:22:38 -0600 Rating Details
2024-03-08 06:18:05 -0600 Rating Details
2024-03-08 05:59:31 -0600 Rating Details
2024-03-08 05:57:32 -0600 Rating Details
2024-03-15 01:37:04 -0500 Rating Details
2024-03-15 01:36:41 -0500 Rating Details
2024-03-15 01:31:04 -0500 Rating Details
2024-03-12 10:52:30 -0500 Rating Details